In a reflection of the changing landscape for academic drug discovery at the University of Michigan, the Center for the Discovery of New Medicines will now be known as Michigan Drug Discovery.
Along with the change in name, comes a shift in direction, scope and emphasis.
The University of Michigan Center for the Discovery of New Medicines has awarded early-stage funding for seven new drug discovery projects by faculty from across U-M.
The Center for the Discovery of New Medicines has awarded funding for five new drug discovery projects by U-M faculty that address critical health areas including chronic kidney disease, ovarian cancer, breast cancer, toxoplasmosis and atherosclerosis.
Vincent Groppi, a leader in pharmaceuticals and biotechnology, is the new director of U-M's Center for the Discovery of New Medicines.
The CDNM is a virtual center that supports early-stage, innovative drug-discovery research projects across the university and is administratively housed at the Life Sciences Institute.
The Center for the Discovery of New Medicines has awarded its third round of grants, providing funding to eight projects from labs across U-M.